Streetbeat News

Analyst Ratings

PLL

Piedmont Lithium (NASDAQ:PLL) reported Q3 earnings of $0.88 per share, missing the analyst consensus estimate of $1.51 by 41.72%. The company also reported quarterly sales of $47.10 million, missing the analyst consensus estimate of $50.29 million by 6.34%. However, this is a 225.71% increase over losses from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

November 07, 2023 | 11:48 am

ACVA

Needham analyst Chris Pierce has reiterated a 'Buy' rating on ACV Auctions (NASDAQ:ACVA) and maintained a price target of $23.

Portfolio Pulse from Benzinga Newsdesk

November 07, 2023 | 11:48 am

OLPX

Olaplex Hldgs (NASDAQ:OLPX) reported Q3 adjusted earnings of $0.05 per share, beating the analyst consensus estimate of $0.04 by 25%. However, this is a 54.55% decrease from the same period last year. The company also reported quarterly sales of $123.60 million, beating the analyst consensus estimate of $116.65 million by 5.96%, but this is a 29.95% decrease from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

November 07, 2023 | 11:46 am

OCN

Ocwen Financial reported Q3 earnings of $1.10 per share, beating the analyst consensus estimate of $1.08 by 1.85%. However, this is a 73.62% decrease from the same period last year. The company's quarterly sales of $255.50 million missed the analyst consensus estimate of $268.01 million by 4.67%, but it's a 2.31% increase from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

November 07, 2023 | 11:46 am

EVER

Needham analyst Mayank Tandon maintains a 'Buy' rating on EverQuote (NASDAQ:EVER) and raises the price target from $8 to $10.

Portfolio Pulse from Benzinga Newsdesk

November 07, 2023 | 11:44 am

EVRG

Evergy reported Q3 adjusted earnings of $1.88 per share, beating the analyst consensus estimate of $1.83 by 2.73%. However, this is a 6.47% decrease from the same period last year. The company's quarterly sales of $1.67 billion missed the analyst consensus estimate of $1.92 billion by 13.07%, marking a 12.57% decrease from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

November 07, 2023 | 11:42 am

RVMD

Needham analyst Ami Fadia has reiterated a 'Buy' rating on Revolution Medicines (NASDAQ:RVMD) and maintained a price target of $36.

Portfolio Pulse from Benzinga Newsdesk

November 07, 2023 | 11:39 am

DHI

D.R. Horton reported Q4 earnings of $4.45 per share, beating the analyst consensus estimate of $3.93 by 13.23%. However, this is a 4.71% decrease from the same period last year. The company also reported quarterly sales of $10.50 billion, beating the analyst consensus estimate of $10.01 billion by 4.94%, and marking an 8.97% increase from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

November 07, 2023 | 11:31 am

COMP

Needham analyst Bernie McTernan has maintained a 'Buy' rating on Compass (NYSE:COMP) but lowered the price target from $4 to $3.

Portfolio Pulse from Benzinga Newsdesk

November 07, 2023 | 11:19 am

AYX

Needham analyst Mike Cikos has reiterated a Buy rating on Alteryx (NYSE:AYX) and maintained a $42 price target.

Portfolio Pulse from Benzinga Newsdesk

November 07, 2023 | 11:16 am